Levy Kopelovich Selected Research

Levy Kopelovich Research Topics

Disease

96	Neoplasms (Cancer) 10/2019 - 03/2002
39	Carcinogenesis 06/2019 - 03/2002
21	Colonic Neoplasms (Colon Cancer) 02/2015 - 03/2003
20	Inflammation (Inflammations) 01/2022 - 11/2003
13	Breast Neoplasms (Breast Cancer) 08/2017 - 01/2007
12	Colorectal Neoplasms (Colorectal Cancer) 06/2019 - 03/2002
11	Carcinoma (Carcinomatosis) 07/2016 - 03/2003
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 03/2004
9	Skin Neoplasms (Skin Cancer) 02/2014 - 07/2002
8	Adenoma (Adenomas) 01/2016 - 03/2003
8	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2011 - 03/2002
7	Obesity 01/2022 - 03/2011
7	Basal Cell Carcinoma (Rodent Ulcer) 01/2017 - 03/2004
6	Adenocarcinoma 01/2016 - 09/2005
5	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 09/2003
4	Transitional Cell Carcinoma 01/2016 - 08/2013
4	Urinary Bladder Neoplasms (Bladder Cancer) 07/2014 - 03/2005
4	Body Weight (Weight, Body) 01/2013 - 04/2006
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 11/2007
3	Residual Neoplasm 01/2017 - 01/2013
3	Melanoma (Melanoma, Malignant) 12/2015 - 10/2005
3	Neoplasm Metastasis (Metastasis) 12/2015 - 05/2009
3	Papilloma (Papillomatosis) 01/2011 - 07/2002
3	Aberrant Crypt Foci 09/2010 - 10/2009
2	Tuberous Sclerosis (Bourneville's Disease) 03/2017 - 12/2004
2	Adenocarcinoma of Lung 12/2015 - 09/2013
2	Lung Neoplasms (Lung Cancer) 12/2015 - 09/2013
2	Li-Fraumeni Syndrome 06/2014 - 03/2014
2	Rhabdomyosarcoma 06/2013 - 08/2010

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 06/2019 - 03/2004
14	Biomarkers (Surrogate Marker)IBA 10/2019 - 09/2008
13	CP 31398IBA 07/2016 - 12/2007
12	Pharmaceutical PreparationsIBA 12/2015 - 12/2003
11	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2015 - 03/2003
9	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 12/2003
8	Sulindac (Copal)FDA LinkGeneric 02/2015 - 03/2003
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2015 - 11/2003
8	CarcinogensIBA 09/2013 - 01/2005
7	Aromatase (CYP19)IBA 01/2022 - 03/2011
7	EnzymesIBA 02/2015 - 07/2002
7	AzoxymethaneIBA 02/2015 - 04/2006
7	Hormones (Hormone)IBA 09/2013 - 11/2006
7	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2008 - 07/2002
6	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016 - 06/2006
6	Celecoxib (Celebrex)FDA Link 02/2015 - 04/2006
6	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2015 - 11/2003
6	Transcription Factors (Transcription Factor)IBA 06/2014 - 06/2009
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2013 - 11/2003
5	Sirolimus (Rapamycin)FDA Link 02/2019 - 07/2011
5	Estrogen ReceptorsIBA 08/2017 - 01/2007
5	Estrogens (Estrogen)FDA Link 08/2017 - 01/2009
5	nitroxy-butyl-acetylsalicylic acidIBA 06/2011 - 11/2003
4	PolyaminesIBA 01/2016 - 03/2004
4	Cyclin D1IBA 01/2016 - 09/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 06/2009
4	Eflornithine (Ornidyl)FDA Link 09/2013 - 11/2003
4	GW 501516IBA 07/2013 - 05/2005
4	Progesterone Receptors (Progesterone Receptor)IBA 07/2013 - 04/2012
4	Caspase 3 (Caspase-3)IBA 01/2013 - 12/2007
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013 - 04/2006
4	ProteomeIBA 03/2011 - 06/2007
4	ResveratrolIBA 01/2011 - 07/2006
4	PPAR gammaIBA 01/2009 - 03/2002
4	TeaIBA 01/2009 - 07/2002
3	Naproxen (Naprosyn)FDA LinkGeneric 01/2021 - 11/2009
3	Cadherins (E-Cadherin)IBA 01/2017 - 07/2011
3	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 07/2016 - 10/2010
3	MicroRNAs (MicroRNA)IBA 12/2015 - 01/2013
3	ProstaglandinsIBA 02/2015 - 11/2003
3	LigandsIBA 06/2014 - 09/2005
3	CateninsIBA 02/2014 - 01/2010
3	Folic Acid (Vitamin M)FDA LinkGeneric 09/2013 - 02/2011
3	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 09/2013 - 03/2004
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2013 - 03/2002
3	Atorvastatin (Lipitor)FDA Link 01/2013 - 04/2006
3	2-chloro-5-nitrobenzanilideIBA 01/2013 - 03/2012
3	CyclinsIBA 09/2012 - 03/2008
3	styrylquinazolineIBA 07/2012 - 12/2007
3	anthraceneIBA 05/2012 - 01/2009
3	Progestins (Progestagens)IBA 05/2012 - 05/2005
3	Messenger RNA (mRNA)IBA 10/2010 - 10/2005
3	NF-kappa B (NF-kB)IBA 06/2009 - 11/2003
3	Phosphotransferases (Kinase)IBA 06/2009 - 10/2006
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2008 - 12/2007
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2008 - 07/2002
3	ErbB Receptors (EGF Receptor)IBA 07/2007 - 04/2005
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2017 - 01/2009
2	trans-sodium crocetinate (crocetin)IBA 03/2017 - 12/2004
2	VimentinIBA 01/2017 - 07/2011
2	licofeloneIBA 01/2016 - 07/2014
2	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 12/2015 - 09/2013
2	TOR Serine-Threonine KinasesIBA 12/2015 - 07/2007
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2014 - 03/2004
2	Biological ProductsIBA 01/2014 - 04/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2013 - 03/2011
2	MethyltransferasesIBA 08/2013 - 02/2011
2	Glucose (Dextrose)FDA LinkGeneric 07/2013 - 01/2010

Therapy/Procedure

24	Chemoprevention 01/2021 - 11/2003
7	Therapeutics 08/2017 - 05/2005
2	Caloric Restriction 01/2022 - 04/2013